OPERATIONS

Technology Medicaleaf™ has invested considerable to create ‘state of the art’ web-based online platforms for each brand (MMP and ) and e-commerce engines that will:

Co-ordinate prescription ordering from medical specialists via chemists or for direct delivery.

Follow up specific evidenced feedback from prescribing specialists.

Boast an intelligent personal health ‘avatar’ to assist consumers maintain health and wellbeing. Provide advice and support to specialists with robust knowledge centre delivered by qualified staff. Provide an online payment system and ordering platform for well-being, health and cosmetic products for both commercial partners and direct consumers. Provide a suitable CRM solution for the sales team to manage distribution partners and for the platform to auto-manage website visitors and enquirers. Encourage global organic sales growth through loyalty and reward schemes.

In addition, Medicaleaf ™ will invest appropriately in the necessary accounting, marketing, communication and payment processing hard and software wherever necessary in order to optimise each individual’s effectiveness and keep control of headcount.

Medicaleaf™ have developed an innovative tool to be used by medical practitioners prescribing Cannabis Based Medical Products, (CBMP’s). We call it ‘MIPA’ – The Medicaleaf Intelligent Prescription App, (Patent pending). The tool, using an ‘app’ constantly gathers personal data from the individual, their medical history and any evidential medical tests (e.g. blood tests) and using a proprietary algorithm developed with professorial insight and guidance, is able to make and review a parametric prescription that the medical specialist can safely rely on and compare against Meta Data. We believe this medical innovation will become the ‘go to’ technology for all holistic prescriptions and will form part of the NHS’s drive toward ‘personalised medicine’. Indeed it’s application has potential to reach far beyond CBMP’s and will eventually be monetised by licence. Medicaleaf™ are already working with NIHR/NHS to demonstrate concept and efficacy.

CONFIDENTIAL - DO NOT DISSEMINATE. This business plan contains confidential, trade-secret information and is shared only with the understanding that you will not share its contents or ideas with third parties without the express written consent of the plan author.